Contemporary Left Ventricular Assist Device Outcomes in an Aging Population
No abstract yet
We only have this paper's title and publication details.
Read it at the sourceKey expert perspectives
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“Not only do as well for the most part as younger patients with these devices, but in some ways they actually seem to tolerate them much better than what conventional wisdom would be.”
“They reduce wear and tear. They seem to be less thrombogenic, so there's much lower risk of pump thrombosis and blood clots, which obviously can cause stroke. And you [can] anticoagulate less aggressively, so there's less risk of major bleeding, and they seem to be less prone to chronic infections.”
Discussion
No takes yet. Share an insight, caveat, or question.
Cite This Study
Emerson et al. (2021) studied this question.